Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost-benefit analysis. Claus BOM, De Smedt D, De Cock PA. J Antimicrob Chemother 2025;80:857-867.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Claus BOM, De Smedt D, De Cock PA. Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost-benefit analysis. J Antimicrob Chemother 2025;80:857-867.
PMID: 39869440